original ) (raw )Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells
Meenakshi Chellaiah
Cell Communication and Signaling, 2019
View PDFchevron_right
Identification of Function for CD44 Intracytoplasmic Domain (CD44-ICD): MODULATION OF MATRIX METALLOPROTEINASE 9 (MMP-9) TRANSCRIPTION VIA NOVEL PROMOTER RESPONSE ELEMENT
Marina Chekmareva
Journal of Biological Chemistry, 2012
View PDFchevron_right
Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface
Meenakshi Chellaiah
Journal of Cellular Biochemistry, 2009
View PDFchevron_right
Promising noninvasive cellular phenotype in prostate cancer cells knockdown of matrix metalloproteinase 9
Aditi Gupta
TheScientificWorldJournal, 2013
View PDFchevron_right
Differential Expression of CD44 During Human Prostate Epithelial Cell Differentiation
Alex Hudson
Journal of Histochemistry & Cytochemistry, 2004
View PDFchevron_right
Silencing of CD44 Expression in Prostate Cancer by Hypermethylation of the CD44 Promoter Region
Theodorus Van Der Kwast
Laboratory Investigation, 2000
View PDFchevron_right
γ-Secretase-Dependent Proteolysis of CD44 Promotes Neoplastic Transformation of Rat Fibroblastic Cells
Serge Manié
Cancer Research, 2006
View PDFchevron_right
The CD44 Isoforms in Prostate Cancer Metastasis and Progression
Peter Graham
World Journal of Cancer Research
View PDFchevron_right
CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration
Motowo Nakajima
Oncogene, 1999
View PDFchevron_right
Expression profile of standard and variants forms of CD44 related to prostate cancer behavior
Jose Pontes
The International Journal of Biological Markers, 2014
View PDFchevron_right
Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration
Hiroaki Kinoh
Journal of Cell Biology, 2001
View PDFchevron_right
The Runx2 Osteogenic Transcription Factor Regulates Matrix Metalloproteinase 9 in Bone Metastatic Cancer Cells and Controls Cell Invasion
Janet Stein
Molecular and Cellular Biology, 2005
View PDFchevron_right
Mutant Allele of CD44 (rs8193C>T) and Pum2 Regulatory Element as A Prognosis Factor of Prostate Neoplasms: A Case-Control and In Silico Studies
Cell Journal Yakhteh
Cell J, Vol 24, No 12, December , 2022
View PDFchevron_right
Analysis of anomalous CD44 gene expression in human breast, bladder, and colon cancer and correlation of observed mRNA and protein isoforms
Kazuhiro Yoshida
American Journal Of Pathology
View PDFchevron_right
De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer
P. Eschwège
Journal of Clinical Pathology, 1998
View PDFchevron_right
Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis
Aditi Gupta
Molecular Cancer, 2012
View PDFchevron_right
Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts
Steven Mooney
Medical oncology (Northwood, London, England), 2015
View PDFchevron_right
Mechanism and biological significance of CD44 cleavage
Osamu Nagano
Cancer Science, 2004
View PDFchevron_right
Prostate cancer invasion is influenced more by expression of a CD44 isoform including variant 9 than by Muc18
Girish Shah
Laboratory Investigation, 2004
View PDFchevron_right
CD44: A Multifunctional Mediator of Cancer Progression
Aiman Mohtar
Biomolecules
View PDFchevron_right
Decreased expression of cd44 in metastatic prostate cancer
Theodorus Van Der Kwast
International Journal of Cancer, 1999
View PDFchevron_right
Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway
Albert Wong
Journal of Cell Biology, 2001
View PDFchevron_right
DECREASED CD44 EXPRESSION IN METASTATIC PROSTATE CANCER
Theodorus Van Der Kwast
J Urol, 1999
View PDFchevron_right
Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma
Jesús Planagumà
Human pathology, 2011
View PDFchevron_right
A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis
Borhane Annabi
Clinical & Experimental Metastasis, 2005
View PDFchevron_right
CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase
Yoshifumi Itoh
Oncogene, 2005
View PDFchevron_right
Integrin alphavbeta3 and cd44 pathways in metastatic
Aditi Gupta
View PDFchevron_right
Methylation of the CD44 metastasis suppressor gene in human prostate cancer
Michael Becich
Cancer research, 1999
View PDFchevron_right
Expression of alternatively spliced forms of the CD44 extracellular-matrix receptor on human lung carcinomas
Rolf Stahel
International Journal of Cancer, 1994
View PDFchevron_right
Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue
R. Lichtinghagen
European urology, 2002
View PDFchevron_right
CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin-like domain
Naohiko Koshikawa , Hidetoshi Mori
The EMBO Journal, 2002
View PDFchevron_right
The complex CD44 transcriptional unit: Alternative splicing of three internal exons generates the epithelial form of CD44
Edward W. Baptist
Biochemical and Biophysical Research Communications, 1992
View PDFchevron_right